Skip to main content
. Author manuscript; available in PMC: 2007 Oct 22.
Published in final edited form as: J Mol Biol. 2007 Mar 15;369(1):142–156. doi: 10.1016/j.jmb.2007.02.103

Table 6.

Impact of APH(3′)-IIIa mutations on resistance, enzyme-drug binding affinity, and catalysis

APH(3′)-IIIa MIC (μM)a Ka (M−1)b Km (μM)c kcat (s−1)c
Neo
none 6 n.a. n.a. n.a.
wt 1600 (4.2 ± 1.5) × 107 18.2 ± 1.6 1.7 ± 0.1
E157A 800 (7.6 ± 0.2) × 106 14.7 ± 1.7 1.3 ± 0.1
E160A 1600 (1.4 ± 0.1) × 106 25.2 ± 5.1 2.4 ± 0.2
D190A 6 (1.9 ± 0.2) × 106 n.d. n.d.
D193A 200 (1.9 ± 0.4) × 107 5.9 ± 1.0 0.7 ± 0.1
E230A 1600 (9.1 ± 3.4) × 106 10.0 ± 1.0 1.3 ± 0.1
D261A 12 (1.3 ± 0.3) × 105 3.3 ± 1.5 0.02 ± 0.01
E262A 6 (2.1 ± 0.1) × 104 21.2 ± 5.1 1.9 ± 0.1
ΔF264 12 (1.4 ± 0.1) × 104 10.7 ± 1.8 0.9 ± 0.1
KanB
none 6 n.a. n.a. n.a.
wt 1600 (1.7 ± 0.2) × 107 19.3 ± 6.8 1.9 ± 0.2
E157A 800 (2.2 ± 0.9) × 107 44.1 ± 5.7 2.5 ± 0.1
E160A 400 (2.1 ± 0.1) × 105 42.9 ± 7.2 2.7 ± 0.2
D190A 6 (1.8 ± 0.1) × 106 n.d. n.d.
D193A 1600 (1.3 ± 0.1) × 107 38.7 ± 9.1 2.7 ± 0.2
E230A 1600 (1.1 ± 0.1) × 107 39.8 ± 4.5 2.1 ± 0.1
D261A 12 (1.4 ± 0.1) × 105 9.1 ± 1.0 0.2 ± 0.01
E262A 6 (2.2 ± 0.6) × 103 36.4 ± 4.6 1.2 ± 0.1
ΔF264 12 (6.3 ± 0.2) × 103 16.4 ± 3.0 0.9 ± 0.1
a

Antibacterial activities were assayed in at least two independent experiments. For each drug, the MIC (minimal inhibitory concentration) value obtained was identical in each of the experiments.

b

Values of Ka were derived from fits of the ITC profiles shown in Figure 7. The indicated uncertainties reflect the standard deviations of the experimental data from the fitted curves. n.a. denotes not applicable.

c

Values of Km and kcat were derived from the fits of v versus [S] plots as described in the Materials and Methods, with the indicated uncertainties reflecting the standard deviations of the experimental data from the fitted curves. n.d. denotes not detectable.